Similar Papers

Paper Title
Journal
Date
Author
A phase II study of XL184 in patients (pts) with progressive glioblastoma multiforme (GBM) in first or second relapse
J F De Groot ... T Batchelor
Journal of Clinical Oncology | VOL. 27
J F De Groot, et. al.J F De Groot ... T Batchelor
20 May 2009
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R Stupp ... G Pentheroudakis
Annals of Oncology | VOL. 25
R Stupp, et. al.R Stupp ... G Pentheroudakis
01 Sep 2014
Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review
Oguz Ozel ... Oguzhan Ozdemir
Journal of Oncological Sciences | VOL. 2
Oguz Ozel, et. al.Oguz Ozel ... Oguzhan Ozdemir
01 Aug 2016
Phase I trial of temozolomide plus O6-benzylguanine on three different 5-day temozolomide regimens for patients with progressive glioblastoma multiforme
J A Quinn ... H S Friedman
Journal of Clinical Oncology | VOL. 26
J A Quinn, et. al.J A Quinn ... H S Friedman
20 May 2008
View more papers

More From: International Journal of Neurology and Neurotherapy

Paper Title
Journal
Date
Author
The Utility of IVIG in the Management of Autoimmune Encephalitis: A Retrospective Case Series
Frustaci Katherine ... Eckert Svetlana
International Journal of Neurology and Neurotherapy | VOL. 11
Frustaci Katherine, et. al.Frustaci Katherine ... Eckert Svetlana
31 Dec 2025
Effects of Galactooligosaccharides on the Gut Microbiome in Patients with Alzheimer's Dementia
Adler Georg ... Marczak Agnieszka
International Journal of Neurology and Neurotherapy | VOL. -
Adler Georg, et. al.Adler Georg ... Marczak Agnieszka
31 Dec 2025
-
-
International Journal of Neurology and Neurotherapy | VOL. 11
--
31 Dec 2025
Predicting CGRP-Antagonists Response Based on the Phenotypic Features of Migraine Headaches, a Retrospective Study
Zidan Awss ...
International Journal of Neurology and Neurotherapy | VOL. -
Zidan Awss, et. al.Zidan Awss ...
31 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.